Andrew recently co-founded twoXAR, a pharmaceutical company rooted in computational drug discovery, with his namefellow Andrew A. Radin. The company focuses on developing therapeutics at orders of magnitude faster than traditional drug discovery methods. Andrew also worked in Macquarie Bank’s Fund of Private Equity Fund’s group helping to manage a $200 million Clean Technology Fund. While doing that he was the Race Director for the UCSD Tritonman Triathlon which his team transformed into Southern California’s rst certied sustainable race.
Andrew has Biochem & Econ degrees from UC San Diego and has completed his MBA at MIT Sloan. He has lived, worked, and studied in the US, UK, China, and Australia.